Mechanical ventilation-induced pneumoprotein CC-16
vascular transfer in rats: effect of KGF pretreatment
Olivier
Lesur1,
Cédric
Hermans2,
Jean-François
Chalifour1,
Johanne
Picotte3,
Bruno
Lévy1,
Alfred
Bernard2, and
Denis
Lane1
1 Groupe de Recherche en Physiopathologie
Respiratoire et Unité des Soins Intensifs Médicaux,
Département de Médecine, 3 Service
d'inhalothérapie, Centre Hospitalier Universitaire de
Sherbrooke, Quebec, Canada J1H 5N4; and
2 Unité de Toxicologie Industrielle et
Médecine du Travail, Université Catholique de Louvain, 1200 Brussels, Belgium
 |
ABSTRACT |
After air-blood barrier injury,
"pneumoproteins" specific to lung epithelial distal airspaces
reaching the bloodstream are putative markers of lung
hyperpermeability. The contribution of mechanical ventilation (MV) to
this leakage is unknown. To explore this issue, 16-kDa Clara cell
protein (CC-16) concentration was quantified in bronchoalveolar lavages
(BALFs) and/or sera of rats first exposed either to ambient air or to
48 h of hyperoxia-induced acute lung injury and then ventilated
for 2 h according to one of the following strategies:
1) spontaneous ventilation (SV), 2)
very-low-volume high PEEP (VLVHP, where PEEP is positive end-expiratory pressure), 3) low-volume zero PEEP, 4)
moderate-volume low PEEP, and 5) high-volume zero PEEP
(HVZP). Results show that total proteins in BALFs increased with time
and MV, with little impact from hyperoxia preexposure. CC-16 content
decreased in BALFs but increased in the bloodstream during MV,
suggesting intravascular leakage. Lung overdistension may result either
from high-volume (HVZP) or high-PEEP (VLVHP) MV, and it was the most
potent inducer of CC-16 leakage (P < 0.05 vs. SV). In
the VLVHP group, pretreatment with keratinocyte growth factor was
efficient in reducing blood CC-16 transfer.
acute lung injury/acute respiratory distress syndrome; ventilation-induced lung injury; 16-kDa Clara cell; keratinocyte growth
factor; pneumoproteinemia
 |
INTRODUCTION |
MECHANICAL VENTILATION
(MV) is an important support therapy to patients admitted in intensive
care units for respiratory failure. New generations of more
sophisticated and computerized respiratory apparatus have allowed
considerable progress over the past half-century (7). In
addition, there have been tremendous advances in our knowledge of
respiratory physiology and pathophysiology under positive-pressure MV.
It is now evident that some ventilatory strategies such as high peak
and plateau airway pressure, high tidal volume, high respiratory
frequency, and high inspiratory flow rate (9, 17, 32, 36,
44), can be deleterious and lead to baro- and/or volotraumas
(1). Complementary studies have suggested that inadequate
cycling collapse and reopening of distal air spaces are also
deleterious but do not exhibit mandatory clinical volo- or
barodisaster, although there is macro- and microscopic evidence of
induced lung injury. These observations have led to new concepts of
ventilation-associated lung injury (in humans) and ventilation-induced
lung injury (VILI; in experimental models) along with the term
"biotrauma," which has been proposed recently as a novel expression
within this framework (13, 25).
Intrapulmonary vascular protein leakage is an essential cogwheel in
VILI observations and is also a hallmark of hyperpermeability syndromes, including acute respiratory distress syndrome (ARDS) and
acute lung injury (ALI; see Refs. 1, 17,
29). This lung protein leakage allows for the distinction
between alterations of the alveolar-capillary (A-C) barrier from high
hydrostatic pulmonary edema in which the barrier is intact and in which
transfer of proteins into the airspaces is low and oncotically
generated (40). All plasmatic proteins can penetrate
inside the lungs, but the predominant protein is serum albumin, a
medium-sized-molecular-mass molecule. However, recent evidence supports
the concept that biological fluid leakage is not exclusively a
one-way process but can be also observed moving from the air spaces to
the systemic circulation (22). This has definitely been
proven by studies measuring proteins specifically produced in lung
airspaces and measurable in the circulation, hence the term
"pneumoproteinemia" (22). Indeed, lung
epithelium-derived small proteins such as surfactant protein (SP)-A, SP-B, 40-kDa rat type I (rTI40)-56-kDa human
type I (HTI56) cell-specific proteins, or 16-kDa Clara cell
protein (CC-16) have all been tested and validated as blood markers of
lung permeability in clinical studies of ALI/ARDS (14, 15, 22,
30, 34). These pneumoproteins could prove to be interesting
sensors of lung hyperpermeability either during the natural history of
ALI/ARDS or when drug-induced reversal of A-C barrier leakage is to be experimentally tested or clinically administered. In this respect, the
fibroblast-derived, epithelial growth-promoting cytokine keratinocyte growth factor (KGF) is a promising molecule shown to efficiently reduce
lung injury in several experimental models (45).
Positive-pressure MV can be a source of lung-to-blood transfer of
molecules such as recently documented for bacteria in a model of
Escherichia coli lung instillation (33),
endotoxins (31), and inflammatory mediators
(43). MV-induced lung-to-blood transfer of molecules
(including pneumoproteins) should a priori be altered by A-C barrier
permeability, such as ALI/ARDS, although the contribution of this
pneumoprotein transfer as an independent parameter has not been
investigated per se.
Hence the main hypotheses of this study are that MV, especially when
strategies potentially leading to lung overdistension are set, is a
significant modulator of pneumoprotein transfer to the bloodstream in
normal and previously injured lungs and that KGF treatment can reduce
this leakage. For this purpose, the following parameters were selected:
1) several MV strategies, including high-volume and/or
high-pressure setups, 2) hyperoxia-induced cellular damage
of the A-C barrier as the archetypal experimental model of lung
hyperpermeability (10), 3) CC-16 as a
peripheral sensitive marker of lung injury, recently validated both
clinically and experimentally (22), and 4) KGF
as the agent targeting epithelial repair in the A-C barrier.
Results of this study demonstrate that 1) differentially
aggressive ventilation strategies can alter both protein blood and bronchoalveolar lavage fluid (BALF) contents, 2) preliminary
alteration of the A-C barrier by hyperoxia can further modulate this
bidirectional leakage process with an emphasis on pneumoprotein CC-16
transfer, and 3) reinforcement of the epithelial side of the
A-C barrier with KGF can reduce lung CC-16 permeability.
 |
METHODS |
Animals.
Experimentation was performed in pathogen-free male Sprague-Dawley rats
(Charles Rivers Laboratories, St. Constant, PQ, Canada) weighing
325-375 g. All animals received care in compliance with The
Guide to the Care and Use of Experimental Animals from the Canadian Council of Animal Care (1993, CCAC, 2nd ed.), and all protocols were approved by our institution's internal animal ethics committee board.
Rats were first anesthetized with xylazine/ketamine (20 and 50 mg/kg
im, respectively), with maintenance intramuscular redosing of 50 mg · kg
1 · h
1
when necessary. A tracheostomy was performed with a 14-gauge cannula
(Insyte; B-D) inserted and secured to the trachea. The right carotid
artery was then denuded, and an angiocatheter (Intramedic polyethylene
tubing, ID 0.023 in., OD 0.038 in.; VWR) was introduced for blood
sampling and gas analysis and maintained open with heparin saline
solution (100 U/ml final concentration). Animals were either left to
breathe ambient air or ventilated using a pediatric constant-flow ventilator (infant pressure ventilator BP200; Bourns Life Systems, Riverside, CA). Additional sedation was given with pentobarbital (ip)
to either group, when necessary. The average duration of surgical
intervention was 20 min, and animal temperature was maintained constant
using an electric pad. All surgical and experimental procedures were
performed in a supine position, and limb contentions were liberated
once surgical cannulations had been performed. Mean arterial pressure
(MAP, mmHg) was screened continuously during the experimental period by
connecting the arterial catheter to a Guardian Datamedix Monitor
through a pressure transducer (PX272; Baxter).
Experimental protocol.
Two populations of animals were subjected to multiple ventilatory
strategies. The first population consisted of rats left in ambient air
with normal unchallenged lungs, whereas the second group was composed
of rats exposed to hyperoxia (>95%) for ~48 h in a Plexiglas
chamber. A maximum of four rats were simultaneously exposed in a
0.25-m3 confined area equipped with a fan and soda lime;
all animals had free access to food and water ad libitum. This model of
hyperoxia was previously validated to induce ALI with vascular leak and epithelial apoptosis. Lung injury culminates after 72-96 h
of hyperoxia, with massive edema, pleural effusion, and respiratory distress, leading to high mortality rates (39). For this
reason, preliminary trials established 48 h as the best time
period for this experimental protocol.
Five ventilatory strategies were explored, including one in spontaneous
ventilation and four with mechanical support: 1) spontaneous ventilation (SV), 2) very-low-volume high PEEP (VLVHP) MV
(where PEEP is positive end-expiratory pressure), 3)
low-volume zero PEEP (LVZP) MV, 4) medium-volume low PEEP
(MVLP) MV, and 5) high-volume zero PEEP (HVZP) MV. MV
strategies were selected to approximate "low-stretch"
"open-lung" ventilation (with permissive hypercarbia) for the VLVHP
group, "low-stretch" controlled hypoventilation (with hypercarbia)
potentially leading to multifocal atelectasis and collapse for the LVZP
group, "high-cycling stretch" with end-expiratory collapse for the
HVZP group, and a relatively neutral adjustment of ventilatory
parameters for the MVLP as a "control" group. These MV setups have
been chosen to represent several conditions where combinations of
delivered volumes and/or exhibited airway pressures to a given animal
can be graded as "nonaggressive" to "aggressive" ventilation
according to present knowledge. Furthermore, a very high-volume zero
PEEP (VHVZP) group was specifically set up to depict a progress profile
of both CC-16 BALF/blood concentrations with increasing tidal volume
(Vt) from LVZP and HVZP to VHVZP. All strategies
were set up for both populations of normal and hyperoxia-exposed rats.
Ventilatory parameters are detailed further in Table
1.
A steady-state period of 2 h (T2 h) of
monitored ventilation was the effective experimental period.
T0 is the time point immediately before
randomization to SV or MV. Initial plasma and gas samples were taken at
T0. Thereafter, a gas analysis was performed
every other 30 min, independent of subset assignment, until
T2 h for the purpose of parameter adjustment,
if needed (Ciba-Corning 238 pH/blood gas analyzer). Normal range values
of arterial acid-base balance targeted for all groups (except VLVHP)
were as follows: pH, 7.35-7.47; PCO2,
28-42 Torr; HCO
, 22-30 mmol/l. Arterial
acid-base values of VLVHP and LVZP groups differed from the other
groups and reached various ranges of values related to mandated
ventilatory parameters, i.e., pH, 7.23 ± 0.04; PCO2, 63.8 ± 6.2 Torr;
HCO
, 23 ± 1.8 mmol/l; and pH, 7.2 ± 0.02; PCO2, 60.6 ± 10.9 Torr;
HCO
, 23 ± 0.3 mmol/l, respectively. Oxygen
supply by cannula or by the input gas mixture of the ventilator was
added to ensure a normal PO2 range of
60-95 Torr. At T2 h, a final gas analysis was performed together with final plasma sampling and a 10-ml PBS
bronchoalveolar lavage (BAL; reinfused three times, recovery 7.5 ± 1 ml) before death. T0 BALs were performed
separately in subsets of rats both exposed and not exposed to hyperoxia.
Normal saline solution was infused intravenously to replace sampling
(300 µl each) and insensible water loss (2 ml/h).
In addition to the core investigation and to assess the impact of
epithelial reinforcement in preventing pneumoprotein leakage, a
subsequent subset of rats was subjected to intratracheal instillation of 5 mg/kg KGF (provided by Dr. Thomas R. Ulich, Amgen, Thousand Oaks,
CA) in 250 µl of vehicle or, in controls, vehicle alone. This
instillation was performed immediately before hyperoxia or ambient air
exposure and 48 h before the steady-state MV period, selecting the
aggressive VLVHP strategy.
Furthermore and in parallel to the above measurements, separate cohorts
of rats (not included for protein leakage determination) were used to
establish respiratory system pressure volume (PV) curves. PV curves
were performed in ambient air and hyperoxia-exposed rats at
T0 and T2 h after MV
settings, as described by others (8). For this purpose,
comparisons were made using the Bourns ventilator and a infant Baby log
(8000; Dräger) equipped with a in-line pneumotachograph, both
devices exhibiting a constant flow system. Inflation of lungs was
performed in 2.5-ml increments to a maximum airway pressure of 30 cmH2O.
Biological fluid processing and analyses.
Blood samples collected by the carotid cannula were centrifuged (1,800 g for 8 min at +4°C), and the sera were separated into aliquots and stored at
80°C.
BALFs were processed as described previously (28). Total
and differential cell counting was performed and revealed enhanced cellularity with MV (either with or without previous hyperoxia) as
follows: five- to eightfold increase of alveolar cells after 2 h of experimentation vs. control rats. Polymorphonuclear
neutrophils became predominant in experimental BALFs (from 35 to 50%
of total cells in all groups) while representing very few cells in
control rats (1.8 ± 1.8%). In addition, after centrifugation,
acellular supernatants were frozen and stored at
80°C. Total
proteins in BALFs were measured according to the method of Lesur et al.
(28). CC-16 concentrations were determined by an automated
latex immunoassay, as described previously (21). This
assay utilizes rat CC-16 protein purified from concentrated BALFs as a
standard, together with a polyclonal antibody raised in rabbit. This
antibody was already shown to recognize a single band of ~16 kDa when
tested in different biological fluids by Western blot analysis
(21). Performances of the assay were similar to that
reported for the human protein (21). Analytical recovery
averaged 90 ± 7%, and the detection limit was 0.5 µg/l.
Creatinine blood content (µmol/l) was determined in initial and final
samplings of experimental rats in an Ektachen multianalyzer using a
classic enzymatic method.
Statistical analysis.
Data are expressed as means ± SD, with each group comprising six
rats. Statistical analyses were performed using ANOVA. Threshold of
significance was set at P < 0.05.
 |
RESULTS |
Respiratory mechanics allowed establishment of the static
compliance of the total respiratory system in our experimental setting. Curves were very similar at T0, either in
ambient air- or 48-h hyperoxia-exposed rats (data not shown). Both
VLVHP and HVZP settings induced a downward shift of the PV curve at
T2 h of the experimentation (Fig.
1).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Static compliance curves of respiratory system.
, Determination of pressure volume (PV) curve at
time 0 (T0), representative of either
ambient air- or hyperoxia-exposed rats (n = 6). Very
low-volume high PEEP ( ; VLVHP; where PEEP is positive
end-expiratory pressure) and high-volume zero PEEP ( ;
HVZP) are representative PV curves of rats either exposed to ambient
air or hyperoxia and after 2 h of mechanical ventilation (MV;
n = 6). Vt, tidal volume. Data are
expressed as means ± SE.
|
|
Basically, a 2-h steady-state period of general anesthesia, either in
SV or with MV, was able to increase overall alveolar-space protein
content by a factor of at least five (Fig.
2). In addition, between MV subsets,
VLVHP was the most distinctive by inducing a further twofold increase
in protein content (P < 0.05 vs. T2 h SV). Hyperoxia (48 h) generally amplified total protein concentration in alveolar fluids regardless of spontaneous or mandated ventilatory conditions and regardless of screening
(T0-T2 h;
P < 0.05 vs. normoxia, except for MVLP; Fig. 2). VLVHP
was again the ventilatory pattern inducing the highest modulation of
protein content. By contrast and presumably because the majority of
proteins in lavages originated from the bloodstream, CC-16 content in
BALFs was decreased by MV (by a factor of 0.6-0.7), with the
exception of MVLP (P < 0.05 vs.
T2 h SV; Fig.
3A). Hyperoxia (48 h)
decreased CC-16 content outright in BALFs before any type of MV
(P < 0.05 vs. ambient air-exposed animals at
T0), whereas a further drop in lung CC-16 was
only observed with the VLVHP strategy after hyperoxia preexposure
(P < 0.05 vs. T2 h SV; Fig.
3A).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Total protein content in bronchoalveolar lavage fluids
(BALFs). Protein concentration in alveolar fluids of experimental rats
were measured at T0 (in a separate set of
animals) and at the end of the steady-state period [time 2 h (T2 h)], as described in
METHODS. Two populations of rats underwent several
ventilatory strategies as follows: 1) control ambient
air-exposed animals (filled bars) and 2) 48-h
hyperoxia-exposed animals (open bars). Ventilatory strategies are
indicated at bottom. The following two different patterns of
ventilation were studied: spontaneous ventilation (SV) and MV. Four
different types of MV were explored as detailed in Table 1:
1) VLVHP, 2) low-volume zero PEEP (LVZP),
3) medium-volume low PEEP (MVLP); and 4) HVZP.
Data are expressed as means ± SD, with each group containing 6 rats. * Significant difference (P < 0.05) between
hyperoxia-exposed and ambient air-exposed groups at
T0. § Significant differences between
T2 h and T0 groups in
respective populations (P < 0.05). Significant
difference (P < 0.05) at
T2 h between rats mechanically ventilated and
those spontaneously breathing.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
The 16-kDa Clara Cell (CC-16) contents in BALFs and
serum. The same presentation as described in Fig. 2 is shown. Data are
expressed as means ± SD, with each group containing 6 rats.
A: CC-16 in BALFs. B: CC-16 in serum.
* Significant difference (P < 0.05) between
hyperoxia-exposed and ambient air-exposed populations at
T0. § Significant differences
(P < 0.05) between MV groups in respective populations
and SV groups at T2 h.
|
|
In contrast with the above BALF data, CC-16 blood content was
significantly and generally enhanced by a factor of >1.5-7 under positive-pressure MV (Fig. 3B), except for LVZP strategy
(P < 0.05 vs. SV at T2 h).
Hyperoxia (48 h) further accentuated this increase in blood CC-16 in
all MV strategies, including LVZP, culminating in a 10-fold increase in
the VLVHP group (P < 0.05 vs.
T2 h SV; Fig. 3B). Analysis of the
CC-16 serum-to-BALF ratio (a candidate marker of the transfer of
pneumoproteins from lung to blood) and the
T0-T2 h differential in
CC-16 serum content (a time-related parameter of blood transfer)
demonstrated that 1) MV is an important independent
contributor of CC-16 blood content, 2) VLVHP and HVZP are
the most inducing MV strategies of CC-16 transfer, and 3)
proportionally, 48 h of hyperoxia further amplifies the pattern
observed, with the exception of VLVHP where a tremendous
disproportional elevation of CC-16 was noted (Fig. 4, A and
B). Indeed, along with VLVHP
MV, there was a 5.5- to 25-fold increase in the serum-to-BALF ratio and
in the T0-T2 h differential of the CC-16 content, respectively (P < 0.05 vs. T2 h SV). In addition, and contrary to
the alterations observed in BALFs, 48-h hyperoxia substantially
increased CC-16 blood content outright (P < 0.05 vs.
T0 SV; Fig. 4, A and B). Furthermore, there was a tight correlation between total protein content in BALFs and CC-16 serum-to-BALF ratios in all four groups of
animals mechanically ventilated (n = 48, r2 = 0.402, P = 0.0001).
Further increase of Vt to extreme levels (~30 ml/kg,
VHVZP) exacerbated lung depletion and serum repletion of CC-16 compared
with LVZP and HVZP groups (Fig.
5A). At 2 h, two out of
six rats in this group were exhibiting similar CC-16 concentrations in
both milieus (2.16 mg/l serum vs. 2.06 mg/l BALF and 2.33 mg/l serum
vs. 2.4 mg/l BALF), suggesting the protein was freely crossing the A-C
barrier. Macroscopic and microscopic evaluations confirmed diffuse,
sometimes hemorrhagic, edema with hyaline membranes and vascular
congestion (Fig. 5, B and C).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Increase in serum-to-BALF (×10 3) CC-16 ratio
(A) and enhanced differential of CC-16 content in serum with
MV (B). Same presentation as described in Fig. 2 is shown.
Data are expressed as means ± SD, with each group containing 6 rats. * Significant difference (P < 0.05) between
hyperoxia-exposed and ambient air-exposed populations at
T0. § Significant differences
(P < 0.05) between MV groups in respective populations
and SV groups at T2 h.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of incremental Vt with zero PEEP on
rat lungs. A: progression of CC-16 BALF ( )
and serum ( ) concentrations with Vt
increase: 7 ml/kg (VLVZP) and 19 ml/kg (HVZP; a) as
described in Table 1 and 28.5 ml/kg (VHVZP, flow rate 11 ± 1 l/min; peak inspiratory pressure, 35 ± 3 cmH2O;
respiratory rate, 20 ± 3 breaths/min; inspiration time, 0.5 ± 1 s; b). B: macroscopic view of dependent
lung areas at the end of the MV period (a and b).
C: representative microscopic view [optical microscopy,
magnification ×400 (a) and ×200 (b),
hematoxylin-eosin] of experimental lungs at the end of the MV period.
Data in A are expressed as means ± SD, with each group
containing 6 rats. Vt values (cc or ml/kg) on the
x-axis are shown on a logarithmic scale.
|
|
Intratracheal instillation of KGF before the 48-h period of hyperoxia
vs. ambient air conditioning allowed for a reduction in CC-16 blood
leakage by 23.5 ± 1.2% (in the ambient air group) and 47 ± 3.9% (in the hyperoxia-exposed group) after 2 h of MV under one
of the most leakage-inducing procedures (i.e., VLVHP). On the other
hand, although the reduction in
T0-T2 h CC-16 serum
content was slight but significant with KGF treatment in ambient air
(175 vs. 228%) and even greater after hyperoxia (307 vs. 410%;
P < 0.05; Fig.
6A), the difference with KGF
treatment for the serum-to-BALF ratio was present only after hyperoxia
(P < 0.05; Fig. 6, A and B).
Protein content in BALFs after KGF treatment returned to values similar
to that observed with SV at T2 h in both
ambient air- and hyperoxia-exposed groups (data not shown). Similar
effects of KGF were observed with the HVZP group.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Serum-to-BALF (×10 3) CC-16 ratio (A) and
T0-T2 h differential
of CC-16 content in serum with keratinocyte growth factor (KGF)
pretreatment before VLVHP. Effect of KGF intratracheal instillation (5 mg/kg in 250 µl of vehicle) vs. vehicle intratracheal instillation
alone (250 µl) on CC-16 lung and blood contents was studied in a
subset of rats (n = 6/set) ventilated with VLVHP. Rats
were initially submitted to a 48-h period of hyperoxia or ambient air,
as described in METHODS. The same presentation as described
in Fig. 2 is shown. Data are expressed as means ± SD.
* Significant differences (P < 0.05) in KGF-treated
and vehicle-treated groups at T2 h.
|
|
A decrease in arterial HCO
(a marker of metabolic
acidosis appearance) was observed at T2 h of
steady-state MV, with decreased concentrations in all conditions after
hyperoxia. In ambient air-exposed lungs, this decrease was apparent
only in the VLVHP group (P < 0.05 vs. SV; Fig.
7). Renal function was
biochemically altered in all groups during the experimental period, as
assessed by a 1.5- to 2-fold increase in blood creatinine (P < 0.05 vs. T0; Table
2). Of note, no significant difference in
renal function was found between experimental groups at
T2 h. MAP was 81.5 ± 4 mmHg at
T0 in experimental groups and decreased overall
to 63 ± 5 mmHg by the end of the 2-h period of observed ventilation, irrespective of hyperoxia or ambient air preexposure. VLVHP and HVZP groups exhibited further decreases of MAP at
T2 h (56 ± 3 mmHg).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
T0-T2 h
alterations in arterial blood HCO concentrations.
The same presentation as described in Fig. 2 is shown. Data are
expressed as differences between T0 and
T2 h HCO concentrations in
means ± SD, with each group containing 6 rats. * Significant
differences between the MV and the SV groups in respective populations
after a 2-h steady-state period of experimentation.
|
|
 |
DISCUSSION |
MV is a determinant of lung protein transfer.
A hallmark of mechanical VILI is pulmonary edema resulting from both
increased filtration (by enhanced pulmonary intravascular pressure) and
alteration of A-C membrane permeability (1, 17, 18). There
is light and electronic microscopy evidence of endothelial and
epithelial injury relative to MV (1, 17). Consecutive lung
hyperpermeability has been studied for small solutes (i.e., 99mTcDTPA) and for larger solutes such as serum albumin and
dextran (20, 38). Increased large protein content in
distal air spaces lacks specificity in this experimental setup. Indeed,
2 h of supine SV under general anesthesia and all types of MV
resulted in at least a 5- to 25-fold increase in total protein content
in rat BALFs. The enhanced alveolar protein content arising from SV is of an unclear mechanism. Multiple factors, including dependent segmental atelectasis in a supine position, may have occurred, but
there was no evidence of light microscopy lung injury or reactive alveolar cellularity (data not shown). By contrast, pneumoprotein CC-16
blood content was clearly more discriminative and was enhanced by
positive-pressure MV compared with SV. Although CC-16 (protein and RNA)
expression by distal epithelial cells has not been studied specifically, a trend toward a decrease in BALF content together with
an increase of blood concentration suggests lung-to-capillary transfer
with MV. This is exemplified further by CC-16 serum-to-BALF ratios and
by the increment of
T0-T2 h CC-16 blood
content. Overdistended or overstretched lung air spaces, either by high end-inspiratory volumes with frequent cyclic reopening and no PEEP
(HVZP) or by maintaining a very high PEEP with minimal flow rate
cycling over the highest inflection point of the PV curve (VLVHP), are
postulated propitious conditions favoring the transfer of CC-16 protein
to the bloodstream, probably by potentiating the progressive increase
in the pore radius, which is physiological at total lung capacity
(12).
Lessons from the other experimental studies regarding the effects of MV
to lung protein permeability are not easy to take in because of a huge
variability in parameters. Indeed, extrapolations are sometimes
problematic, depending on duration of MV, species types, or ventilatory
parameters (whether the chest is open or not, whether the ex vivo lung
is perfused or not, whether a pulmonary insult has been previously
imposed or not, and, if so, whether the injury is endothelial,
epithelial, or both). However, a "too high" PEEP (widely above the
lower inflection point) generally leads to pulmonary edema with
increased extravascular lung water, including epithelial lung fluid
volume (8, 12, 42). Direct lung injury but also
physiological disorders (such as the epithelial pump system
dysfunction) are mechanistic in this way (27). This should
remind us to keep in mind that very extreme PEEP (e.g., 24 cmH2O, or above, at 1.0 fraction of inspired 02
such as in the oxygenation goal chart of the ARDS network; see Ref.
6), even associated with a low "protective"
ventilation, could be occasionally harmful. Indeed, no
definitive MV rules should be drawn (24), whereas
increasing PEEP in animals, even ventilated with low Vt,
can cause edema (16). Comparable results of distal lung injury and A-C barrier permeability have also been described with
zero end-expiratory pressure (ZEEP) (especially when combined with
high-volume MV) or very low PEEP (below the lower inflection point) in study designs similar to our setup (8, 11, 27, 32).
Short-term hyperoxia-induced ALI is a sensitizer of MV-induced
protein lung transfer, without evidence of synergistic effect (except
for CC-16 blood content in the VLVHP group).
Extensive injury of capillary endothelial cells and moderate injury to
alveolar epithelial cells, together with interstitial edema, have been
observed after 60 h of exposure to 100% oxygen in adult rats
(10). Although there is no electron microspopic evidence
of endothelial or epithelial cell alteration until 60 h of
hyperoxia in adult rats, 48 h of hyperoxia substantially increased
total protein content but decreased CC-16 content in BALFs (with a
concomitant rise in blood concentrations) in our experiments.
Consequently, it seems reasonable to postulate that some functional
alteration of the A-C barrier occurs in hyperoxia-exposed lungs before
any morphological changes and before all MV.
Other determinants that could have contributed to the rise of CC-16
blood content after MV (with or without preliminary hyperoxia).
A potential problem using positive-pressure MV in rats arises from the
depression of cardiovascular parameters with time (8, 16),
resulting in a decreased blood pressure (MAP), and, by the way, to
regional blood hypoperfusion, leading to metabolic acidosis highlighted
by a decrease in HCO
arterial blood concentration
(differential T0-T2 h).
Indeed, metabolic acidosis with low pH, per se, has been suggested in favoring increased lung permeability and extravascular lung water in a
model of septic shock by intravenous infusion of live Pseudomonas aeruginosa (37). In the present study
design, only metabolic debt combined with hypercarbia allowed for
arterial pH to approach ~7.2 in both VLVHP and LVZP. On the other
hand, significant alterations in renal function occurring in
conjunction with a reduction of the glomerular filtration rate, a main
pathway for low-molecular-mass protein clearance (5, 22),
most likely contributed to the increase in CC-16 blood content during
the experimental period. Of note, in our study, medium-grade renal
dysfunction was similar between experimental groups, whereas the
alterations in CC-16 blood content were nonproportional and dissimilar
(i.e., huge increase in CC-16 blood content in the hyperoxia/VLVHP
group vs. a mild increase in CC-16 blood content in LVZP and MVLP not
preexposed to hyperoxia, for similar creatinine levels). Mechanisms of
renal dysfunction definitely point to systemic hypoperfusion and
probably to a relatively conservative strategy of volume replacement to sampling and insensible loss.
Pneumoprotein transfer with ALI/hyperpermeability is the main
source of CC-16 blood content.
Ideally, an appealing marker of lung permeability would be of
epithelial origin, sensitive and specific, and easy to measure in the
bloodstream. This involves the recognition of the bidirectional nature
of the alveolocapillary leakage of proteins recently emphasized by
Hermans and Bernard (22). Lung protein leakage is usually described from blood to the air spaces in ALI (40). Yet,
although pneumoproteins of epithelial origin can be detected in minute concentrations in the bloodstream under physiological conditions, they
can also be found in severalfold increased amounts after ALI, when
there is an enhanced passive diffusion through water-filled porous
channels in the tight junctions (14, 15, 22, 30, 33, 34,
45). Actual candidates for pneumoprotein denominations are SP-A,
SP-B, CC-16, and rTI40-HTI56 (14, 15, 22,
30, 33, 34, 45). The first three lung epithelioproteins exhibit relatively low molecular mass (~28-36, 8, and 16 kDa) and have recently been screened as biomarkers of hyperpermeability in patients with ALI/ARDS (14, 15, 22, 30) and in close relationship with the
PaO2-to-FIO2
ratio and alveolar-arterial difference for PO2
(14, 15, 22, 30). No attempt has been made in the above studies to evaluate the contribution of MV adjustment to pneumoprotein leakage, as performed in this study. CC-16, a major secretory product of Clara cells in the terminal bronchioles of the
lung, is one of the most abundant proteins in lung air spaces (~2%
of total proteins) and exhibits immunosuppressive and anti-inflammatory properties (22). Clearance of CC-16 from the bloodstream
is very swift (half-time <18 min) and is glomerular filtration rate dependent (14, 15, 22, 30). Thus, given the huge blood leakage observed in rats exposed to both hyperoxia and VLVHP MV, a
subsequent temporary depletion of CC-16 should have occurred in the
respiratory tract of these animals. Several A-C barrier permeabilizers,
including epithelial and/or endothelial cell toxicants (e.g.,
lipopolysaccharide, Ipomeanol, O3,
-naphtylthiourea), have been reported to severely decrease CC-16 BALF content (2, 3,
23). Of note, matched elevations of CC-16 blood content were
observed in the above experiments. In addition, these
experiments reported a decrease in CC-16 mRNA expression in lung
epithelial cells and a correlated lower number of protein-expressing
cells (2, 3, 23). Although the above protein and RNA
expressions were not specifically assessed in our study, these
alterations may have occurred, together with a Clara cell dysfunction
and deficient CC-16 release. Overall, both depressed CC-16 BALF and increased blood contents can account for several coexisting mechanisms in this work as follows: 1) decreased expression,
production, and/or release at the alveolar interface (several
inflammatory mediators may be contributors in this way) and
2) increased leakage and/or depressed clearance at the blood
interface. However, these data likely suggest that enhanced CC-16 blood
content is a marker of airspace-to-capillary leakage, and this can even
lead to "both side" leveled concentrations of CC-16 in extreme
conditions (e.g., VHVZP).
Prophylactic reinforcement of the epithelial barrier with KGF
reduces CC-16 leakage.
KGF is a powerful repair factor for lung epithelial cells
(35). Systemic or local intratracheal instillation of this
cytokine induces distal air space epithelial cell proliferation over
several days and can help lung restitution when instilled before
bleomycin-, radiation-, acid-, and oxygen-induced ALI (4,
45). Additional potential modes of action in KGF-induced
regulation of alveolar epithelial barrier are also suggested, such as a
reduction in cell apoptosis, increased expression of
surfactant-associated proteins, and upregulation of alveolar liquid
clearance (4, 45). Indeed, VILI produces lung disability
to clear edema, dysfunction of surfactant, and, of course, alteration
of the epithelial side of the A-C barrier (17, 26, 27).
Prolonged hyperoxia produces similar effects but does not change or
increases the ability of the lung to clear edema (19).
Recently, the preventing capacity of KGF to VILI has been reported
using an ex vivo model specific in several points (46) as
follows: KGF was systemically administered, only large-molecular-mass
protein transfer from perfusate to air spaces was measured, and volume
overdistension was moderate in the aggressive arm (i.e., Vt
~4 ml and ZEEP). Reduction in lung water content and dextran BALF
concentrations (46), together with decreases in both CC-16
capillary leakage and total protein content in BALFs (in our study),
were severalfold with KGF treatment. Although the latter data suggest
that KGF controls blood-to-lung protein transfer more efficiently than
the transfer from lung to blood, they also further the argument for an
epithelial dysfunction as a major determinant of lung-to-blood
transfer, whereas KGF was instilled intratracheally. On the other hand,
KGF is already known to decrease CC-16 mRNA expression in the lung
(41). The latter effect likely contributed in lowering
CC-16 BALF content but also in leveling out variations in
serum-to-BALFs ratios and T0-T2 h CC-16 blood concentrations.
In summary, positive-pressure MV alters A-C barrier permeability, even
in the normal lung. CC-16 shows tremendous leakage with lung
overdistension generated by high PEEP or high volume. Preliminary
hyperoxia sensitizes CC-16 transfer to the bloodstream. Additional
determinants of CC-16 blood transfer are systemic hypoperfusion and
accompanying renal dysfunction. KGF is an effective molecule in
reducing combined MV- and hyperoxia-induced lung hyperpermeability to
CC-16.
 |
ACKNOWLEDGEMENTS |
This work was supported by the Clinical Research Center of
Sherbrooke, the Association Pulmonaire du Québec. O. Lesur is a
research scholar of the Fonds de Recherche en Santé du
Québec.
 |
FOOTNOTES |
Address for reprint requests and other correspondence: O. Lesur, Groupe de Recherche en Physiopathologie Respiratoire, Centre de
Recherche Clinique, CHU Sherbrooke, Qc Canada, J1H 5N4 (E-mail: Olivier.Lesur{at}USherbrooke.ca).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published October 25, 2002;10.1152/ajplung.00384.2001
Received 28 September 2001; accepted in final form 21 October 2002.
 |
REFERENCES |
1.
Amato, MB,
and
Marini JJ.
Physiological basis of ventilatory support.
In: Lung Biology in Health and Disease, edited by Lenfant C. New York: Dekker, 1998, vol. 118, p. 1187-1245.
2.
Arsalane, K,
Broeckaert BF,
Knoops B,
Clippe A,
Buchet JP,
and
Bernard A.
Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone.
Toxicol Appl Pharmacol
159:
169-174,
1999[ISI][Medline].
3.
Arsalane, K,
Broeckaert F,
Knoops B,
Wiedig M,
Toubeau G,
and
Bernard A.
Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipolysaccharide administration.
Am J Respir Crit Care Med
161:
1624-1630,
2000[Abstract/Free Full Text].
4.
Barazzone, C,
Donati YR,
Rochat AF,
Vesin C,
Kan C-D,
Pache JC,
and
Piguet PF.
Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice.
Am J Pathol
154:
1479-1487,
1999[Abstract/Free Full Text].
5.
Bernard, A,
Thielemans N,
Lauwerys R,
Vandeleene B,
and
Lambert AE.
The renal handling of protein 1 (Clara cell protein): effect of age, sex, and renal dysfunction.
Contrib Nephrol
101:
66-70,
1993[Medline].
6.
Brower, RG,
and
The Acute Respiratory Distress Syndrome Network
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
N Engl J Med
342:
1301-1308,
2000[Abstract/Free Full Text].
7.
Chatburn, RL.
Principles and practice of mechanical ventilation.
In: Classification of Mechanical Ventilators, edited by Tobin MJ.. New York: McGraw-Hill, 1994, p. 37-64.
8.
Chiumello, D,
Pristine G,
and
Slutsky AS.
Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome.
Am J Respir Crit Care Med
160:
109-116,
1999[Abstract/Free Full Text].
9.
Corbridge, TC,
Wood LD,
Crawford GP,
Chudoba MJ,
Yanos J,
and
Sznadjer JI.
Adverse effects of large tidal volume and low PEEP in canine acid aspiration.
Am Rev Respir Dis
142:
311-315,
1990[ISI][Medline].
10.
Crapo, JD,
Barry BE,
Foscue HA,
and
Shelburne J.
Structural and biochemical changes in rat lung occuring during exposure to lethal and adaptative doses of oxygen.
Am Rev Respir Dis
122:
123-143,
1980[ISI][Medline].
11.
D'Angelo, E,
Pecchiari M,
Baraggia P,
Saetta M,
Balestro E,
and
Milic-Emili J.
Low-volume ventilation causes peripheral airway injury and increased airway resistance in normal rabbits.
J Appl Physiol
92:
949-956,
2000[Medline].
12.
Demling, RH,
Staub NC,
and
Edmunds Jr H.
Effect of end-expiratory airway pressure on accumulation of extravascular lung water.
J Appl Physiol
38:
907-912,
1975[Abstract/Free Full Text].
13.
Dos Santos, CC,
and
Slutsky AS.
Mechanisms of ventilator-induced lung injury: a perspective.
J Appl Physiol
89:
1645-1655,
2000[Abstract/Free Full Text].
14.
Doyle, IR,
Bersten AD,
and
Nicholas TE.
Surfactant proteins-A, and -B are elevated in plasma of patients with acute respiratory failure.
Am J Respir Crit Care Med
156:
1217-1229,
1997[Abstract/Free Full Text].
15.
Doyle, IR,
Hermans C,
Bernard A,
Nicholas TE,
and
Bersten AD.
Clearance of Clara cell secretory protein (CC-16) and surfactant proteins-A and -B from blood in acute respiratory failure.
Am J Respir Crit Care Med
158:
1528-1535,
1998[Abstract/Free Full Text].
16.
Dreyfuss, D,
and
Saumon G.
Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation.
Am Rev Respir Dis
148:
1194-1203,
1993[ISI][Medline].
17.
Dreyfuss, D,
and
Saumon G.
Ventilator-induced lung injury.
Am J Respir Crit Care Med
157:
294-323,
1998[Free Full Text].
18.
Dreyfuss, D,
Soler P,
and
Saumon G.
Mechanical ventilation-induced pulmonary edema interaction with previous lung alterations.
Am J Respir Crit Care Med
151:
1568-1575,
1995[Abstract].
19.
Garat, C,
Meignan M,
Matthay MA,
Luo DF,
and
Jayr C.
Alveolar epithelial fluid clearance mechanisms are intact after moderate hyperoxic lung injury in rats.
Chest
111:
1381-1388,
1997[Abstract/Free Full Text].
20.
Guery, BP,
Nelson S,
Viget N,
Fialdes P,
Summer WR,
Dobard E,
Beaucaire G,
and
Mason CM.
Fluorescein-labeled dextran concentration is increased in BAL fluid after ANTU-induced edema in rats.
J Appl Physiol
85:
842-848,
1998[Abstract/Free Full Text].
21.
Halatek, T,
Hermans C,
Broeckaert F,
Wattiez R,
Wiedig M,
Toubeau G,
Falmagne P,
and
Bernard A.
Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay.
Eur Respir J
11:
726-733,
1998[Abstract/Free Full Text].
22.
Hermans, C,
and
Bernard A.
Lung epithelium specific proteins: characteristics and potential applications as markers.
Am J Respir Crit Care Med
159:
646-768,
1999[Free Full Text].
23.
Hermans, C,
Knoops B,
Wiedig M,
Arsalane K,
Toubeau G,
Falmagne P,
and
Bernard A.
Clara cell protein as marker of Clara cell damage and bronchoalveolar blood barrier permeability.
Eur Respir J
13:
1014-1021,
1999[Abstract/Free Full Text].
24.
Hubmayr, RD.
Perspective on lung injury and recruitment. A skeptical look at the opening and collapse story.
Am J Respir Crit Care Med
165:
1647-1653,
2002[Free Full Text].
25.
International Consensus Conferences in Intensive Care Medicine.
Ventilator-associated lung injury in ARDS.
Am J Respir Crit Care Med
160:
2118-2124,
1999[Free Full Text].
26.
Ito, Y,
Veldhuizen RAW,
Yao L-J,
McCaig LA,
Bartlett AJ,
and
Lewis JF.
Ventilation strategies affect surfactant aggregate conversion in acute lung injury.
Am J Respir Crit Care Med
155:
493-499,
1997[Abstract].
27.
Lecuona, E,
Saldias F,
Comellas A,
Ridge K,
Guerrero C,
and
Sznajder JI.
Ventilator-associated lung injury decreases lung ability to clear edema in rats.
Am J Respir Crit Care Med
159:
603-609,
1999[Abstract/Free Full Text].
28.
Lesur, O,
Arsalane K,
and
Lane D.
Lung alveolar epithelial cell migration in vitro: modulators, and regulation processes.
Am J Physiol Lung Cell Mol Physiol
270:
L311-L319,
1996[Abstract/Free Full Text].
29.
Lesur, O,
Berthiaume Y,
Blaise G,
Damas P,
Deland E,
Guimond JG,
and
Michel RP.
Acute respiratory distress syndrome (ARDS): thirty years later.
Can Resp J
6:
71-86,
1999[Medline].
30.
McElroy, MC,
Wiener-Kronish JP,
Miyazaki H,
Sawa T,
Modelska K,
Dobbs LG,
and
Pittet JF.
Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats.
Am J Physiol Lung Cell Mol Physiol
272:
L631-L638,
1997[Abstract/Free Full Text].
31.
Murphy, DB,
Cregg N,
Tremblay L,
Engelberts D,
Laffey JG,
Slutsky AS,
Romaschin A,
and
Kavanagh BP.
Adverse ventilatory strategy causes pulmonary-to-sytemic translocation of endotoxin.
Am J Respir Crit Care Med
162:
27-33,
2000[Abstract/Free Full Text].
32.
Muscedere, JG,
Mullen JBM,
Gan K,
and
Slutsky AS.
Tidal ventilation at low pressures can augment lung injury.
Am J Respir Crit Care Med
149:
1327-1334,
1994[Abstract].
33.
Nahum, A,
Hoyt J,
Schmitz L,
Moody J,
Shapiro R,
and
Marini JJ.
Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs.
Crit Care Med
25:
1733-1743,
1997[ISI][Medline].
34.
Newman, V,
Gonzalez RF,
Matthay MA,
and
Dobbs LG.
A novel alveolar type I cell-specific biochemical marker of human acute lung injury.
Am J Respir Crit Care Med
161:
990-995,
2000[Abstract/Free Full Text].
35.
Panos, RJ,
Rubin JS,
Aaronson SA,
and
Mason RJ.
Keratinocyte growth factor, and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.
J Clin Invest
92:
969-977,
1993[ISI][Medline].
36.
Peevy, KJ,
Hernandez LA,
Moise AA,
and
Parker JC.
Barotrauma and microvascular injury in lungs of nonadult rabbits: effect of ventilation pattern.
Crit Care Med
18:
634-637,
1990[ISI][Medline].
37.
Pittet, J-F,
Wiener-Kronish JP,
Serikof V,
and
Matthay MA.
Resistance of the alveolar epithelium to injury from septic shock in sheep.
Am J Respir Crit Care Med
151:
1093-1100,
1995[Abstract].
38.
Ramanathan, R,
Mason GR,
and
Raj JU.
Effect of mechanical ventilation, and barotrauma on pulmonary clearance of 99m technitium diethylenetriamine pentaacetate in lambs.
Pediatr Res
27:
70-74,
1990[Abstract].
39.
Ryan, SF.
Acute lung injury: experimental models.
In: Models of Lung Diseases. Lung Biology in Health and Disease, edited by Lenfant C,
and Gil J.. New York: Dekker, 1990, vol. 47, chapt. 21, p. 641-733.
40.
Schuster, DP.
Pulmonary edema.
In: Pulmonary Diseases and Disorders, edited by Fishman AP.. New York: McGraw-Hill, 1998; chapt. 85, p. 1331-1356.
41.
Toshiyuki, Y,
Deterding RR,
Nielsen LD,
Jacoby C,
Shannon JM,
and
Mason RJ.
Surfactant protein and CC-10 expression in acute lung injury and in response to keratinocyte growth factor.
Chest
111, Suppl 6:
137S-138S,
1997[Free Full Text].
42.
Toung, T,
Saharia P,
Permutt S,
Zuidema GD,
and
Cameron JL.
Aspiration pneumonia: beneficial and harmful effects of positive end-expiratory pressure.
Surgery
82:
279-283,
1997.
43.
Tremblay, L,
Valenza F,
Ribeiro SP,
Li J,
and
Slutsky AS.
Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model.
J Clin Invest
99:
944-952,
1997[Abstract/Free Full Text].
44.
Tsuno, K,
Prato P,
and
Kolobow T.
Acute lung injury from mechanical ventilation at moderately high airway pressures.
J Appl Physiol
69:
956-961,
1990[Abstract/Free Full Text].
45.
Ware, LB,
and
Matthay MA.
Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation and repair.
Am J Physiol Lung Cell Mol Physiol
282:
L924-L940,
2002[Abstract/Free Full Text].
46.
Welsh, DA,
Summer WR,
Dobard EP,
Nelson S,
and
Mason CM.
Keratinocyte growth factor prevents ventilator-induced lung injury in an ex vivo rat model.
Am J Respir Crit Care Med
162:
1081-1086,
2000[Abstract/Free Full Text].
Am J Physiol Lung Cell Mol Physiol 284(2):L410-L419
1040-0605/03 $5.00
Copyright © 2003 the American Physiological Society